Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response

Published:2019-01-01 Issue:1 Volume:41 Page:104-112
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Deng Fei¹,Zhang Jingwei²,Li Yi¹,Wang Wei¹,Hong Daqing¹,Li Guisen¹,Feng Jing³

Affiliation:

1. Department of Nephrology, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital, Chengdu, PR China;

2. Department of Laboratory Medicine, Chengdu Second People’s Hospital, Chengdu, PR China;

3. Department of Traditional Chinese Medicine, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital, Chengdu, PR China

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2019.1583113

Reference33 articles.

1. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

2. Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists

3. Donepezil Combined with Natural Hirudin Improves the Clinical Symptoms of Patients with Mild-to-Moderate Alzheimer's Disease: A 20-Week Open-Label Pilot Study

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hirudin in the Treatment of Chronic Kidney Disease;Molecules;2024-02-27

2. Traditional Chinese medicine for the treatment of immune-related nephropathy: A review;Acta Pharmaceutica Sinica B;2024-01

3. Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease;Renal Failure;2023-12-11

4. Gubentongluo decoction alleviates NLRP3 inflammasome in IgAN cell model;All Life;2023-01-17

5. A Molecular Mechanism Study to Reveal Hirudin’s Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFRβ in Renal Fibrosis Treatment;BioMed Research International;2022-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3